¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"essential progressive atrophy of iris"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® atrophy ÇÑ±Û À§Ãà(Áõ)
¼³¸í   
  Á¶Á÷À̳ª ¼¼Æ÷ È¤Àº ±â°üÀÇ Å©±â°¡ ¿ø·¡ÀÇ Å©±â¿¡ ºñÇÏ¿© ÁÙ¾îµå´Â °ÍÀ» ÀÏÄ´ ¸». Ã³À½ºÎÅÍ Å©±â°¡ ÀÛÀº ¹«Çü¼º/Çü¼ºÀúÇÏÁõ(aplasia/hypoplasia)¿Í ±¸º°µÈ´Ù.
¿µ¹® iris ÇÑ±Û È«Ã¤
¼³¸í   
  ¾È±¸ÀÇ °¢¸·°ú ¼öÁ¤Ã¼ »çÀÌ¿¡ Àִ µÕ±Ù ¸ð¾çÀÇ ¾ãÀº ¸·. ¸·ÀÇ Áß¾Ó¿¡ µ¿°øÀÌ ÀÖÀ¸¸ç, È«Ã¤ÀÇ ½ÅÃàÀ¸·Î µ¿°øÀÌ Ãà¼ÒµÇ°Å³ª È®´ëµÇ¾î ¾È±¸¿¡ µé¾î¿À´Â ºûÀÇ ¾çÀ» Á¶ÀýÇÑ´Ù. ÀÎÁ¾¿¡ µû¶ó »ö¼Ò°¡ ´Ù¸¥´Ù. ´«µ¿ÀÚÀÇ ÁÖÀ§¿¡ Àִ °í¸® ¸ð¾çÀÇ ¸·, °ËÀº ´«µ¿ÀÚÀÇ º»Ã¼´Â °¢¸·À» ÅëÇØ Èæ»öÀ¸·Î º¸À̴ ȫäÀÌ´Ù. Áß¾Ó¿¡ ¿øÇüÀÇ µ¿°øÀÌ ÀÖ°í, ÀÌ °÷À» ÅëÇÏ¿© Àü¾È¹æ°ú ÈľȹæÀÌ À̾îÁø´Ù. È«Ã¤°¡ ÀÌ¿ÏÇϰųª ¼öÃàÇÔ¿¡ µû¶ó µ¿°øÀÇ Å©±â°¡ º¯Ç졒ʵû¶ó¼­ ¸Á¸·¿¡ ´ÞÇϴ ±¤¼±ÀÇ ¾çÀÌ Á¶ÀýµÈ´Ù. Áï, È«Ã¤´Â Ä«¸Þ¶óÀÇ Á¶¸®°³¿¡ ÇØ´çÇÑ´Ù. È«Ã¤ÀÇ À̿ϰú ¼öÃàÀº ±× ¼Ó¿¡ Àִ µ¿°ø»ê´ë±Ù ¹× µ¿°øÁ¶ÀÓ±Ù¿¡ ÀÇÇÏ¿© ÀÌ·ç¾îÁø´Ù. È«Ã¤ÀÇ ¿ÜÁÖ¿¬Àº ¼¶¸ðü¿¬À̶ó°í Çϸç, ¸ð¾çü¿¡ ¿¬°áµÇ¾î ÀÖ´Ù. ¶Ç ³»Ãø¿¬, Áï µ¿°øÀÇ ¿ÜÁÖ¿¬Àº µ¿°ø¿¬À̶ó°í ÇÑ´Ù. È«Ã¤ÀÇ Á¶Á÷Àº »ö¼Ò¼¼Æ÷°¡ Ç³ºÎÇÑ ÃþÀ¸·Î µÇ¾î Àִµ¥, ±× »ö¼ÒÀÇ ºû±òÀ̳ª Ç÷°üÀÇ ´Ù¼Ò¿¡ ÀÇÇÏ¿© È«Ã¤ÀÇ ºû±òÀÌ ´Þ¶ó º¸ÀδÙ.
  
  È«Ã¤
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • progressive spinal muscular atrophy
    ÁøÇàô¼ö¼º±Ù(À°)À§ÃàÁõ
  • coloboma of iris
    ȫä°á¼Õ
  • iris
    ȫä
  • iris bombe
    ȫ亼·Ï, È«Ã¤ÆØÀå
  • iris collarette
    ȫäÀÜ°í¸®, ȫäºÐÇÒ·û
  • iris contraction reflex
    ȫä¼öÃà¹Ý»ç
  • iris crypt
    ȫä¿ò, ȫä¿Í
  • iris floccule
    ȫ伨¼Òü, ȫ伨ÅÐü
  • iris frill
    ȫä±ÇÃà·û, ȫäºÐÇÒ·û
  • iris prolapse
    ȫäŻÃâ
  • iris spatula
    ȫäÁÖ°Æ, ȫä´Ù·ç°³
  • iris sphincter
    µ¿°øÁ¶ÀÓ±Ù, µ¿°ø°ý¾à±Ù, Ãൿ±Ù
  • plateau iris
    °í¿øÈ«Ã¤
  • essential
    1. º»ÅÂ- 2. Ư¹ß- 3. Çʼö-, Áø¼º-
  • essential amino acid
    Çʼö¾Æ¹Ì³ë»ê
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • iris
    ȫä
  • rapidly progressive glomerulonephritis
    ±Þ¼ÓÁøÇàÅ丮ÄáÆÏ¿°, ±Þ¼ÓÁøÇà»ç±¸Ã¼½Å¿°
  • progressive bulbar palsy
    ÁøÇà¼û³ú¸¶ºñ, ÁøÇ࿬¼ö¸¶ºñ
  • essential tremor
    º»Å¶³¸², À¯Àü¶³¸², ¿øÀθ𸦶³¸²
  • essential vertigo
    ¿øÀκҸí¾îÁö·³, º»ÅÂÇö±âÁõ
  • atrophy
    ˤ̈
  • choroidal atrophy
    ¸Æ¶ô¸·À§Ãà, ¾ôÈû¸·À§Ãà
  • optic atrophy
    ½Ã°¢½Å°æÀ§Ãà
  • optic nerve atrophy
    (¢¡optic atrophy) ½Ã°¢½Å°æÀ§Ãà
  • spinal muscular atrophy
    ô¼ö±ÙÀ°À§Ãà(Áõ)
  • thenar atrophy
    ¾öÁöµÎµ¢À§Ãà
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • essential progressive deafness
    Ư¹ßÁøÇ೭û
  • neural progressive muscular atrophy
    ½Å°æÁøÇà±ÙÀ°À§Ãà
  • coloboma of iris
    ȫä°á¼Õ
  • iris collarette
    ȫäÀÜ°í¸®, ȫäºÐÇÒ·û
  • iris crypt
    ȫä¿ò
  • iris floccule
    ȫ伨¼Òü, ȫ伨ÅÐü
  • iris frill
    ȫä±ÇÃà·û, ȫäºÐÇÒ·û
  • iris
    ȫä
  • iris bombe
    ȫ亼·Ï, È«Ã¤ÆØ¸¢
  • iris prolapse
    ȫäŻÃâ
  • iris spatula
    ȫäÁÖ°Æ, ȫä´Ù·ç°³
  • iris sphincter
    (¢¡pupillae muscle) µ¿°øÁ¶ÀÓ±Ù
  • iris contraction reflex
    ȫä¼öÃà¹Ý»ç
  • plateau iris
    °í¿øÈ«Ã¤
  • tremulous iris
    (¢¡iridodonesis) ȫä¶³¸²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • generalized essential telangiectasia
    Àü½Å¼º º»Å¼º ¸ð¼¼Ç÷°ü È®Àå(Áõ)
  • hypertension,essential
    º»Å¼º(Üâ÷¾àõ)
  • infantile progressive spinal muscular atrophy
    ¿µ¾ÆÁøÇ༺ ô¼ö¼º ±ÙÀ§Ãà(Áõ).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(¡­ãêÌèàõÐÉê×õê).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(òäú¼àõ ãêÌèàõ ÐÉê×õê)
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõø¸äÔØüê×õê ).
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõ ø¸äÔØüê×õê )
  • Iris
    ȫä
  • Iris
    ȫä[Á¶¸®°³]
  • greater arterial circle of iris
    ūȫ䵿¸Æ°í¸®
  • greater circle of iris
    ūȫäµÑ·¹
  • greater ring of iris<³ª> anulus iridis major
    ´ëȫä·û(ÓÞûöóôëÌ).
  • plateau iris
    °í¿øÈ«Ã¤
  • prolapse of iris
    ȫäŻÃâ(Áõ)(ûöóô÷­õóñø).
  • prolapse of iris ³ª prolapsus iridis
    ȫäŻÃâ(Áõ)(ûöóô÷­õó(ñø))
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • essential iris atrophy
    º»Å¼ºÈ«Ã¤À§Ãà, Ư¹ß¼ºÈ«Ã¤À§Ãà
  • essential progressive deafness
    Ư¹ß¼º ÁøÇà(¼º) ³­Ã»
  • iris atrophy
    ȫäÀ§Ãà
  • infantile progressive spinal muscular atrophy
    ¿µ¾ÆÁøÇ༺ ô¼ö¼º ±ÙÀ§Ãà(Áõ).
  • juvenile progressive muscular atrophy
    ¿¬¼Ò¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ(¡­òäú¼àõÐÉê× õêñø).
  • myopathic progressive muscular atrophy
    ±Ùº´Áõ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõÐÉê×õêñø).
  • neural progressive muscular atrophy
    ½Å°æ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ).
  • neural progressive muscular atrophy
    ½Å°æ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõ ÐÉê×õêñø)
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(¡­ãêÌèàõÐÉê×õê).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(òäú¼àõ ãêÌèàõ ÐÉê×õê)
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõø¸äÔØüê×õê ).
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõ ø¸äÔØüê×õê )
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõÐÉê× õêñø).
  • collarettes of the iris
    ȫü±ÇÃà·û, ȫüºÐÇÒ·û
  • coloboma of iris
    ȫü°á¼Õ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lesser arterial circle of iris
    ÀÛÀºÈ«Ã¤µ¿¸Æ°í¸®
    [¿¾ ¿ë¾î] ¼Òȫ䵿¸Æ·û
  • Greater arterial circle of iris
    ūȫ䵿¸Æ°í¸®
    [¿¾ ¿ë¾î] ´ëȫ䵿¸Æ·û
  • Greater circle of iris
    ūȫäµÑ·¹
    [¿¾ ¿ë¾î] ´ëȫä·û
  • Stroma of iris
    ȫä¹öÆÀÁú
    [¿¾ ¿ë¾î] ȫäÁöÁú
  • Lesser circle of iris
    ÀÛÀºÈ«Ã¤µÑ·¹
    [¿¾ ¿ë¾î] ¼Òȫä·û
  • Iris
    ȫä [Á¶¸®°³]
    [¿¾ ¿ë¾î] ȫä
  • Iris
    ȫä[Á¶¸®°³]
    [¿¾ ¿ë¾î] ȫä
  • Myopigmentocyte of iris
    ȫä±ÙÀ°»ö¼Ò¼¼Æ÷
    [¿¾ ¿ë¾î] ȫä±Ù»ö¼Ò¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    À§Ãà (ê×õê)
  • essential amino acid
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«)
  • essential amino acid index
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«) Áö¼ö(ò¦â¦)
  • essential enzyme
    Çʼö È¿¼Ò (ù±âÎý£áÈ)
  • essential fatty acid
    Çʼö Áö¹æ»ê (ù±âÎò·Û¸ß«)
  • essential gene
    Çʼö À¯ÀüÀÚ (ù±âÎë¶îîí­)
  • essential metabolite
    Çʼö ´ë»ç¹° (ù±âÎÓÛÞóÚª)
  • essential nutrient
    Çʼö ¿µ¾ç¼Ò (ù±âÎç½å×áÈ)
  • essential oil
    ÇʼöÀ¯(ù±âÎêú)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • essential hypertension
    º»Å¼º°íÇ÷¾Ð
  • iris
    ȫä
  • progressive
    ÁøÇ༺ÀÇ, ÁøÁ÷(¼º)ÀÇ
  • progressive diaphyseal dysplasia
    ÁøÇ༺°ñ°£¼ºÀÌÇü¼º(Áõ)
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺´ÙÃÊÁ¡¼º¹éÁú³úº´Áõ
  • progressive muscle dystrophy
    ÁøÇ༺±ÙÀÌ¿µ¾çÁõ
  • progressive spinal amyotrophy
    ÁøÇ༺ô¼ö¼º±ÙÀ§ÃàÁõ
  • atrophy
    À§ÃàÁõ, ¹«¿µ¾çÁõ
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • muscle atrophy
    ±ÙÀ§Ãà
  • muscular atrophy
    ±ÙÀ§Ãà
  • neurogenic muscular atrophy
    ½Å°æ¼º±ÙÀ§Ãà(Áõ)
  • optic atrophy
    ½Ã½Å°æÀ§Ãà
  • optic nerve atrophy
    ½Ã½Å°æÀ§Ãà
  • senile atrophy
    ³ë³â(³ëÀÎ)¼ºÀ§Ãà
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ET educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e...
ICL idiopathic CD4 T-cell lymphocytopenia; iris-clip lens; isocitrate lyase
IRIS integrated risk information system; interleukin regulation of immune system; International Research ...
VID visible iris diameter
PMA index of prevalence and severity of gingivitis, where P = papillary gingiva, M = marginal gingiva, a...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PRA Progressive retinal atrophy
PMA progressive muscular atrophy
IPE Iris pigment epithelium
ICB iris ciliary body
IPE iris pigment epithelial
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • juvenile progressive muscular atrophy
    ¿¬¼Ò¼º ÁøÇ༺ ±Ù À§ÃàÁõ
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ
    ô¼ö ¹× ¿¬¼öÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ÀÇ º¯¼º¿¡ ÀÇÇÏ¿© Àü½ÅÀÇ ±ÙÀ§Ãà°ú Å»·ÂÀ» ÀÏÀ¸Å°´Â º´. ¼Õ, ¹ßÀÇ ±ÙÀ° À§Ãà¿¡¼­ ½ÃÀÛÇÏ¿© Á¡Â÷·Î »óÇàÇØ¼­ ¸ñÀÇ ±ÙÀ°°ú ¸öÅëÀÇ ±ÙÀ°µµ Ä§ÇØµÈ´Ù. »ó, ÇÏÁöÀÇ ÈûÁٹݻ簡 ¾àÇØÁö°í ¹Ùºó½ºÅ° ¹Ý»ç´Â À½¼ºÀÌ µÈ´Ù. °æ°ú°¡ ±æ°í Á¶±â¿¡ »ç¸ÁÇÏ´Â ÀÏÀº ¾øÀ¸³ª, °«³­¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ º´À» º£¸£Æ®´ÏÈ÷-È£ÇÁ¸¸ º´À̶ó°í Çϸç, ¼ö³â À̳»¿¡ »ç¸ÁÇÑ´Ù. ¶Ç À̰Ͱú ±Ù¿¬°ü°è¿¡ ÀÖ´Â °¡Á·¼º ô¼ö¼º ±ÙÀ§¼º ±Ù À§ÃàÁõµµ ÀÌ º´ÀÇ ÇÑ ÇüÀÌ´Ù. 3¼¼ ÀÌÈÄÀÇ ¾î´À ¿¬·ÉÃþ¿¡¼­³ª ¹ßº´ÇÏ¸ç ±ä °æ°ú¸¦ ÃëÇÑ´Ù. Ư¼öÇÑ Ä¡·á¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ ÇÊ¿äÇÏ´Ù.
  • iris contraction reflex
    ȫä ¼öÃà ¹Ý»ç
    µ¿ÀǾî=
  • iris-nevus syndrome
    ȫä ¸ð¹Ý ÁõÈıº
  • iris-type
    ȫä ¸ð¾ç
  • myopigmentocyte of iris
    ȫä ±ÙÀ° »ö¼Ò ¼¼Æ÷
  • Eagle`s minimal essential medium
    ÀÌ±Û ¹èÁö
    ¼¼Æ÷ ¹è¾ç¾×ÀÇ ÀÏÁ¾. 3Á¾·ùÀÇ ¾Æ¹Ì³ë»ê°ú 8Á¾·ùÀÇ ºñŸ¹ÎÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç º¸Åë Ç÷û 5% ÀÌÇÏ¿¡¼­ À¯Áö ¹èÁö·Î¼­ »ç¿ëµÇ°í 10-20%ÀÇ Ç÷û ÷°¡·Î ¸¹Àº ¼¼Æ÷´Â ±ØÈ÷ ¾çÈ£ÇÑ ¹ßÀ°À» ³ªÅ¸³½´Ù.
  • essential amino acid
    Çʼö ¾Æ¹Ì³ë»ê
    ´Ü¹éÁúÀÇ ±âº» ±¸¼º ´ÜÀ§. ´Ü¹éÁúÀº ü³»¿¡¼­ ¾Æ¹Ì³ë»êÀ¸·Î ºÐÇØµÇ°í ³ª¼­ Èí¼ö, ÀÌ¿ëµÈ´Ù. µû¶ó¼­ ´Ü¹éÁúÀÇ ¿µ¾ç°¡´Â ±× ¼Ó¿¡ ÇÔÀ¯µÇ´Â ¾Æ¹Ì³ë»êÀÇ Á¾·ù¿Í ¾ç¿¡ ÀÇÇÏ¿© Á¤ÇØÁø´Ù. ¾Æ¹Ì³ë»êÀº µ¿¹°ÀÇ Ã¼³»¿¡¼­ ´Ù¸¥ ¾Æ¹Ì³ë»êÀ¸·ÎºÎÅÍ ¸¸µé¾îÁö´Â °Í°ú, ü³»¿¡¼­´Â ÇÕ¼ºµÇÁö ¾Ê°í À½½ÄÀ¸·Î ¼·ÃëµÇ¾î¾ß ÇÏ´Â °ÍÀÌ ÀÖ´Ù. µû¶ó¼­ ¼·ÃëÇÏÁö ¾ÊÀ¸¸é ¿ÏÀüÇÑ ´Ü¹éÁúÀÌ µÇÁö ¾Ê´Â´Ù. ÀÌ·¸°Ô ü³»¿¡¼­ ÇÕ¼ºÇÒ ¼ö ¾ø´Â ¾Æ¹Ì³ë»êÀ» Çʼö ¾Æ¹Ì³ë»ê ¶Ç´Â ºÒ°¡°á ¾Æ¹Ì³ë»êÀ̶ó°í ÇÑ´Ù. Çʼö ¾Æ¹Ì³ë»êÀÇ Á¾·ù´Â µ¿¹°ÀÇ Á¾·ù³ª ¼ºÀå ½Ã±â¿¡ µû¶ó ´Ù¸£Áö¸¸, ¼ºÀÎÀÇ °æ¿ì¿¡´Â ´ÙÀ½ÀÇ 8Á¾ÀÌ´Ù. À̼ҷù½Å, ·ù½Å, ¸®½Å, Æä´Ò¾Ë¶ó´Ñ, ¸ÞƼ¿À´Ñ, Æ®·¹¿À´Ñ, Æ®¸³ÅäÆÇ, ¹ß¸°ÀÌ´Ù. ¾î¸°¾ÆÀÌÀÇ °æ¿ì¿¡´Â ¿©±â¿¡ È÷½ºÆ¼µòÀÌ ´õÇØÁø´Ù.
  • essential fatty acid
    Çʼö Áö¹æ»ê
    °íµîµ¿¹°ÀÇ ¼ºÀå ¶Ç´Â °Ç°­ »óÅÂÀÇ À¯Áö¸¦ À§ÇÏ¿© ü¿Ü·ÎºÎÅÍ ¼·ÃëÇØ¾ß ÇÒ Áö¹æ»ê. ºñŸ¹Î F¶ó°íµµ ÇÑ´Ù. Áö¹æÀº ü³»¿¡¼­ ÁÖ·Î ¿¡³ÊÁö¿øÀÌ µÇ¹Ç·Î ´Ù¸¥ °ÍÀ¸·ÎºÎÅÍ Ä®·Î¸®¸¦ ÃëÇϸé Áö¹æÀº ÇÊ¿ä¾øÁö ¾ÊÀº°¡ ÇÏ´Â Àǹ®ÀÌ »ý±ä´Ù. ±×·¯³ª À½½Ä ¼Ó¿¡ Áö¹æÀÌ ÀüÇô ¾øÀ¸¸é µ¿¹°ÀÇ ¼ºÀåÀÌ Á¤ÁöÇÏ°í Æ¯À¯ÇÑ ÇǺο°ÀÌ »ý±ä´Ù. ÀÌ Áõ¼¼´Â ¸®³î»ê, ¸®³î·»»ê, ¾Æ¶ó۵·»ê Áß ¾î´À °ÍÀ» ÇÔÀ¯ÇÏ´Â Áö¹æÀ» Åõ¿©Çϸé Ä¡À¯µÈ´Ù. ±×·¡¼­ À̵é Áö¹æÀ» ¾Æ¹Ì³ë»êÀÇ ¿¹¿¡ µû¶ó Çʼö Áö¹æ»êÀ̶ó°í ÇÑ´Ù. ÀÌ»óÀÇ ¼¼ °¡Áö Áö¹æ»ê Áß¿¡¼­ ¸®³î»êÀº ÀϹÝÀûÀÎ À¯Áö¿¡ ³Î¸® ÇÔÀ¯µÇ¾î ÀÖÀ¸¹Ç·Î, º¸ÅëÀÇ Áö¹æÀ» ¼·ÃëÇϸé Áö¹æ»êÀÌ °áÇÌÇÏ´Â ÀÏÀº ¾ø´Ù.
  • essential hypertension
    º»Å¼º °íÇ÷¾Ð
    1. Ưº°ÇÑ ¿øÀÎÀÌ ¾Ë·ÁÁöÁö ¾ÊÀº °íÇ÷¾ÐÀ» ÀǹÌÇϸç ÀÌ´Â Àüü °íÇ÷¾Ð ȯÀÚÀÇ 85-90£¥¸¦ Â÷ÁöÇÑ´Ù. 2. À¯Àü, Á¤½ÅÀû ½ºÆ®·¹½º, ¿°ºÐÀÇ Áõ°¡ µî Ç÷¾Ð »ó½ÂÀÌ º¹ÇÕÀûÀÎ ¿øÀÎ ÇüÅ·Π³ªÅ¸³­´Ù.
  • essential mixed cryoglobulinemia
    ¿ø¹ß¼º È¥ÇÕ ÇѳÃ-±Û·Îºí¸°Áõ
    µå¹® Àü½Å¼º ÁúȯÀ¸·Î¼­ IgG-IgM º¹ÇÕü°¡ ÁÖ ¼ººÐÀÎ ÇѳÃ-±Û·Îºí¸°ÀÇ Ä§ÂøÀ¸·Î ÇǺΠÇ÷°ü¿°, Ȱ¸·¿° ¹× ÃÊÁ¡¼º ³»Áö ¹Ì¸¸¼º Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°ÀÌ ³ªÅ¸³­´Ù. CÇü °£¿°°ú °°Àº °¨¿°¿¡ ¼Ó¹ßÇÏ´Â ÇѳÃ-±Û·Îºí¸°Ç÷Áõ¿¡¼­´Â ¸·Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°ÀÌ °üÂûµÇ±âµµ ÇÑ´Ù.
  • essential oil
    Á¤À¯
  • essential tremor
    Ư¹ß¼º ÁøÀü
    ¾ç¼ºÀÇ À¯ÀüÀû °¡Á·Àû Ãßü ¼¼Æ÷¿Ü ÁøÀü
  • minimum essential medium
    ÃÖ¼Ò Çʼö ¹èÁö
  • chronic progressive disciform granulomatosis
    ¸¸¼º ÁøÇ༺ ¿øÆÇ»ó À°¾ÆÁ¾Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
essential progressive atrophy of iris Progressive atrophy of the iris without inflammatory signs, characterised by patchy loss of all layers of the iris with hole formation, migration of the pupil, degeneration of the corneal endothelium, peripheral anterior synechiae, and secondary glaucoma; usually unilateral, predominantly affecting women in their middle years.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
progressive choroidal atrophy An x chromosome-linked abnormality characterised by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.
(12 Dec 1998)
progressive circumscribed cerebral atrophy Circumscribed atrophy of the cerebral cortex.
Synonym: lobar sclerosis, progressive circumscribed cerebral atrophy.
(05 Mar 2000)
progressive infantile spinal muscular atrophy Transmitted as autosomal recessive on chromosome 5q. Progressive dysfunction of the anterior horn cells in the spinal cord and brainstem cranial nerves with profound weakness and bulbar dysfunction occurring in the first two years of life. Three groups, based on age of clinical onset, are recognised.
Synonym: familial spinal muscular atrophy, Hoffmann's muscular atrophy, infantile muscular atrophy, infantile progressive spinal muscular atrophy, progressive infantile spinal muscular atrophy, Werdnig-Hoffmann disease, Werdnig-Hoffmann muscular atrophy.
(05 Mar 2000)
progressive muscular atrophy A serious neurologic disease that results from the progressive degeneration of the motor neurons.
(27 Sep 1997)
progressive spinal muscular atrophy One of the subgroups of motor neuron disease; a progressive degenerative disorder of the motor neurons of the spinal cord, manifested as progressive, often symmetrical, weakness and wasting, typically beginning in the distal portions of the limbs, particularly in the upper extremities, and spreading proximally; fasciculation potentials are often present, but evidence of corticospinal tract disease (e.g., increased deep tendon reflexes, Babinski sign) is not.
(05 Mar 2000)
infantile progressive spinal muscular atrophy Transmitted as autosomal recessive on chromosome 5q. Progressive dysfunction of the anterior horn cells in the spinal cord and brainstem cranial nerves with profound weakness and bulbar dysfunction occurring in the first two years of life. Three groups, based on age of clinical onset, are recognised.
Synonym: familial spinal muscular atrophy, Hoffmann's muscular atrophy, infantile muscular atrophy, infantile progressive spinal muscular atrophy, progressive infantile spinal muscular atrophy, Werdnig-Hoffmann disease, Werdnig-Hoffmann muscular atrophy.
(05 Mar 2000)
benign essential tremor A benign tremor inherited as a dominant character; it may be a rapid oscillation resembling that seen in thyrotoxicosis, a coarse tremor during rest and inhibited by a voluntary effort, or one which appears only upon movement.
Synonym: benign essential tremor, familial tremor.
(05 Mar 2000)
drugs, essential Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3)
(12 Dec 1998)
osteolysis, essential Syndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive (gorham disease), multicentric (hajdu-cheney syndrome, winchester syndrome), or carpal/tarsal.
(12 Dec 1998)
Eagle's minimum essential medium A tissue culture medium similar to Eagle's basal medium but with different amounts and a few exclusions (e.g., antibiotics and phenol red).
(05 Mar 2000)
essential 1. Belonging to the essence, or that which makes an object, or class of objects, what it is. "Majestic as the voice sometimes became, there was forever in it an essential character of plaintiveness." (Hawthorne)
2. Hence, really existing; existent. "Is it true, that thou art but a a name, And no essential thing?" (Webster (1623))
3. Important in the highest degree; indispensable to the attainment of an object; indispensably necessary. "Judgment's more essential to a general Than courage." (Denham) "How to live? that is the essential question for us." (H. Spencer)
4. Containing the essence or characteristic portion of a substance, as of a plant; highly rectified; pure; hence, unmixed; as, an essential oil. "Mine own essential horror."
5. Necessary; indispensable; said of those tones which constitute a chord, in distinction from ornamental or passing tones.
6. <medicine> Idiopathic; independent of other diseases.
<biology> Essential character, a class of volatile oils, extracted from plants, fruits, or flowers, having each its characteristic odour, and hot burning taste. They are used in essences, perfumery, etc, and include many varieties of compounds; as lemon oil is a terpene, oil of bitter almonds an aldehyde, oil of wintergreen an ethereal salt, etc.; called also volatile oils in distinction from the fixed or nonvolatile.
Origin: Cf. F. Essentiel. See Essence.
Source: Websters Dictionary
(01 Mar 1998)
essential albuminuria A collective term for types that are not the result of pathologic changes in the kidneys.
Synonym: essential albuminuria.
(05 Mar 2000)
essential amino acid <biochemistry> Those amino acids that cannot be synthesised by an organism and must therefore be present in the diet. The term is often applied anthropocentrically to those amino acids required by humans (Ileu, Leu, Lys, Met, Phe, Thr, Try, & Val), though rats need two more (Arg & His).
(18 Nov 1997)
essential amino acids Alpha-amino acids nutritionally required by an organism and which must be supplied in its diet (i.e., cannot be synthesised by the organism) either as free amino acid or in proteins.
(05 Mar 2000)
essential anaemia An obsolete term for pernicious anaemia; also used formerly for any type of anaemia of unknown mechanism.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    À§Ãà; ¼è¾à
  • atrophy
    ¼è¾à;¼è¾àÇÏ´Ù;À§ÃàÇÏ´Ù
  • iris
    ȫä
  • iris
    ȫä;Âüº×²É¼ÓÀÇ;º×²É;ÈÆ»ö(¹«Áö°³ºû)ÀÇ ¼®¿µ;(¿©ÀÚÀ̸§)(±×½Å)À̸®½º(¹«Áö°³ÀÇ ¿©½Å)
  • iris diaphragm
    (·»ÁîÀÇ)ȫäÁ¶¸®°³
  • essential
    º»ÁúÀûÀÎ,ÇʼöÀÇ
  • non-essential
    ºñº»ÁúÀûÀÎ
  • essential
    º»ÁúÀûÀÎ;½ÇÁúÀÇ;ÇʼöÀÇ;Á¤¼öÀÇ;¿¡¼¾½ºÀÇ;±âº»ÀÇ;º»Áú;¿äÁ¡;¿ä¼Ò
  • essential amino acid
    (È­)Çʼö ¾Æ¹Ì³ë»ê
  • essential oil
    (½Ä¹°¼º)Á¤À¯;¹æÇâÀ¯(Çâ¼öÀÇ ¿ø·á)
  • progressive
    ÀüÁøÀûÀÎ
  • Progressive Party
    Áøº¸´ç
  • progressive
    ÀüÁøÇÏ´Â;´©ÁøÀûÀÎ;Áøº¸ÁÖÀÇÀÇ;ÁøÇàÇüÀÇ(progressive jazz ºñÀçÁîÀû ¿ä¼Ò¸¦ °¡¹ÌÇÑ ¸ð´ø ÀçÁîÀÇ ÇÑ ¾ç½Ä,progressive taxation ´©Áø °ú¼¼);Áøº¸·ÐÀÚ;Áøº¸´ç¿ø
  • progressive country
    (1970³â´ë¿¡ »ý±ä) ÄÁÆ®¸® ¹ÂÁ÷ÀÇ ÀÏÁ¾
  • progressive education
    Áøº¸ÁÖÀÇ ±³À°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á